Apelin stimulates glucose utilization in normal and obese insulin-resistant mice
about
Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesityAdipokines - removing road blocks to obesity and diabetes therapyThe APJ receptor: a new therapeutic approach in diabetic treatmentAdipokines in breast milk: an updateCentral chronic apelin infusion decreases energy expenditure and thermogenesis in mice.Gut Microbiota Modulation and Its Relationship with Obesity Using Prebiotic Fibers and Probiotics: A ReviewApelin is necessary for the maintenance of insulin sensitivity.Association of genetic variants in the apelin-APJ system and ACE2 with blood pressure responses to potassium supplementation: the GenSalt studyThe role of adipose tissue and adipokines in obesity-related inflammatory diseasesApelin treatment increases complete Fatty Acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice.Oxidative stress and metabolic pathologies: from an adipocentric point of view.Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms.Oral Administration of Semicarbazide Limits Weight Gain together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue.Apelin ameliorates TNF-α-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ.Resveratrol metabolites modify adipokine expression and secretion in 3T3-L1 pre-adipocytes and mature adipocytesGut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertensionTransition from metabolic adaptation to maladaptation of the heart in obesity: role of apelinAPpEaLINg therapeutic target for obesity cardiomyopathy?Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue.Apelin and insulin resistance: another arrow for the quiver?Apelin and energy metabolism.Adipokines as drug targets in diabetes and underlying disturbances.Structural apelin analogues: mitochondrial ROS inhibition and cardiometabolic protection in myocardial ischaemia reperfusion injury.Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.Apelin regulates FoxO3 translocation to mediate cardioprotective responses to myocardial injury and obesity.Clinical relevance of adipokines.Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1α-dependent function.Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.Apelin as a marker for monitoring the tumor vessel normalization window during antiangiogenic therapyAssociations of common variants at APLN and hypertension in Chinese subjects with and without diabetes.Assessment of Serum Concentrations of Ghrelin, Obestatin, Omentin-1, and Apelin in Children with Type 1 Diabetes.Is the adipose tissue a key target of developmental programming of adult adiposity by maternal undernutrition?Apelin-13 administration protects against ischaemia/reperfusion-mediated apoptosis through the FoxO1 pathway in high-fat diet-induced obesity.Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance.Once fat was fat and that was that: our changing perspectives on adipose tissue.Effects of dietary eicosapentaenoic acid (EPA) supplementation in high-fat fed mice on lipid metabolism and apelin/APJ system in skeletal muscle.Getting the message across: mechanisms of physiological cross talk by adipose tissue.Hypothalamic apelin/reactive oxygen species signaling controls hepatic glucose metabolism in the onset of diabetes.Apelin attenuates oxidative stress in human adipocytes.
P2860
Q26828547-A0E93C5A-6348-439B-AAF1-BA0441ABE563Q26995825-9419C717-CDDA-459D-BECF-5E716F43DFAAQ27025069-4AE3729D-E28E-437B-8E3C-020821F9CE7FQ27026251-F6DA82CA-C5C3-4A74-BBCF-EF640AE4D559Q27316188-94D4A85F-027F-48BF-A1DB-E4195CD025CEQ30234753-57F6E907-42D6-4E9D-A59B-B5927CEBACC0Q33589049-13DDCBFE-FBAF-40D0-8E7C-2D8E4C36DE8EQ33932245-FE1310FA-AB34-459F-9473-E00232C566BBQ34022211-BE748C89-1A0E-4F14-A652-4E1DCDA5591BQ34030044-7E41C5B2-0DAC-4F06-94E7-620EFA8ACB84Q34038044-8036FD76-CCE7-4AD4-9FB1-2AAD5B556429Q34548928-995EB4BF-6A3D-4755-A29D-1C831CE1F667Q34572256-5E5A1BC6-1286-43F6-B882-D8384DE9A353Q34600236-EBD390D8-5C96-4E2E-A8B1-8E8A5F365870Q34744832-E0DC6EFB-E08F-4D0D-B444-D5535E3D6341Q34866320-9A48A625-4B37-486C-B073-8F3FEDCECFEBQ35040806-8B2CCA0D-9F20-4B37-BDEF-9836FA5E7756Q35080694-4D09DC4F-3B3E-4269-8221-24B02C372EF7Q35082986-C5C38AD7-5427-4610-8C12-9A983A548CFCQ35114027-24F3ADE2-A8C7-425C-8537-C780AF23401EQ35166911-E2144B0F-73E8-4234-A2B2-2487D450FA61Q35352250-976A98F1-243A-4209-9343-3F53B338AFE2Q35415815-2AF6C638-C510-4512-B00D-0B67A238CFFEQ35692991-F5AA0EED-8ED4-4E83-ABE6-CC3985790B4EQ35829203-DC0F50A6-E84A-46DC-85C1-E770BF985600Q36254873-26AF9EF3-9C92-4A42-86A5-CA7DFC52996AQ36365207-BD0F7837-5682-4577-9E97-3753E0010477Q36378405-4EDEA88C-A066-4743-BD69-EE932F6834CDQ36477252-ED98D31D-00E8-4929-8736-511F69DEC1DDQ36495941-1F4803B7-B7B2-49EA-91F8-5BE2A2BC64A3Q36499842-7273D3D6-4FC5-4742-9C9D-4CF4D04E5564Q36556547-FCD4EF24-E42A-4EA5-A72A-112213B813BAQ36866098-6ACFB965-4A2C-4FFA-97E2-0D7BD09A63BCQ36903419-F92F9A06-4C2F-4CCC-95CD-519E7E8607FEQ36915215-DBBF59D8-4DE5-4EA1-9102-75CE0918B81DQ37041935-D33A4B68-121D-44BA-A3F7-E0AD66CE9DCAQ37288696-297B4D56-79E0-44B6-9E21-2CD0E6E0589AQ37405747-F178CA33-F2D6-4515-BF4E-7F996836BC9DQ37513099-A9A006BA-F8FF-4FA8-9AD3-55459E10FC05Q37563582-85B164B6-1E78-412A-A969-3105C8A8A1EF
P2860
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice
@ast
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice
@en
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice
@nl
type
label
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice
@ast
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice
@en
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice
@nl
prefLabel
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice
@ast
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice
@en
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice
@nl
P2093
P50
P921
P3181
P1433
P1476
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice
@en
P2093
Aurélie Waget
Camille Attané
Charlotte Guigné
Christian Carpéné
Danièle Daviaud
Jérémie Boucher
Marie Buléon
Rémy Burcelin
P304
P3181
P356
10.1016/J.CMET.2008.10.003
P407
P577
2008-11-01T00:00:00Z